besifloxacin

Known as: (+)-7-((3R)-3-Aminohexahydro-1H-Azepin-1-yl)-8-Chloro-1-Cyclopropyl-6-Fluoro-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid, 3-Quinolinecarboxylic Acid, 7-((3R)-3-Aminohexahydro-1H-Azepin-1-yl)-8-Chloro-1-Cyclopropyl-6-Fluoro-1,4-Dihydro-4-Oxo-, 7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2018
05101520082018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
PURPOSE Besifloxacin is a novel fluoroquinolone antibiotic developed to provide alternative coverage for ocular pathogens with… (More)
Is this relevant?
2011
2011
PURPOSE To determine the concentrations of besifloxacin, moxifloxacin, and gatifloxacin in human aqueous humor after topical… (More)
Is this relevant?
2010
2010
PURPOSE The purpose of this investigation was to evaluate the ocular pharmacokinetic/pharmacodynamic (PK/PD) relationship for… (More)
Is this relevant?
2010
2010
OBJECTIVES Besifloxacin is a novel fluoroquinolone that was recently approved for topical treatment of bacterial conjunctivitis… (More)
Is this relevant?
2010
2010
PURPOSE To determine the aqueous humor concentrations of moxifloxacin and besifloxacin after routine preoperative topical dosing… (More)
Is this relevant?
2010
2010
PURPOSE To evaluate the pharmacokinetic properties of besifloxacin, gatifloxacin, and moxifloxacin in the conjunctival tissue of… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2009
2009
The antibacterial spectrum of besifloxacin, a novel fluoroquinolone recently approved for treatment of ocular infections, was… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2009
2009
OBJECTIVE To compare the clinical and antimicrobial efficacy of besifloxacin ophthalmic suspension 0.6% with that of vehicle in… (More)
Is this relevant?
2009
2009
BACKGROUND Besifloxacin ophthalmic suspension 0.6% is a new topical fluoroquinolone for the treatment of bacterial conjunctivitis… (More)
Is this relevant?
2009
2009
OBJECTIVE To compare the clinical and antimicrobial efficacy of besifloxacin ophthalmic suspension 0.6% with that of moxifloxacin… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?